Soft Tissue Repair Market Size, by Product Type (Fixation Devices, Tissue Scaffold, Cell-Therapy Based), End-User (Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Physician Office) - Growth Trends, Regional Share, Competitive Intelligence, Forecast Report 2025-2037

  • Report ID: 5530
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Soft Tissue Repair Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037

Soft Tissue Repair Market in 2025 is estimated at USD 16.13 billion. The global Market size was valued at more than USD 15.34 billion in 2024 and is expected to register a CAGR of more than 6.4%, exceeding USD 34.36 billion revenue by 2037. North America is set to approach USD 12.03 billion by 2037, attributed to increased healthcare expenditure and presence of key players.

The market is expanding owing to the growing prevalence of traumatic accidents such as road accidents. According to a report, roughly 1.19 million people lose their lives in vehicle crashes every year. As per estimates, about 20 to 50 million more people experience non-fatal injuries; several of them become disabled. The orthopedic injury resulting from the traffic collision was the primary cause of this disability.

In addition to these, factors that are believed to fuel the market growth of soft tissue repair are growing technological advancements which include the creation of tissue scaffolds, bioengineered grafts, and regenerative medicine methods. Patients are now given access to therapies that encourage tissue regeneration in addition to relieving pain and returning function, which speeds up recovery and improves results.

Soft Tissue Repair Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF


Soft Tissue Repair Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

6.4%

Base Year Market Size (2024)

USD 15.34 billion

Forecast Year Market Size (2037)

USD 34.36 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Soft Tissue Repair Segmentation

Product Type (Fixation Devices, Tissue Scaffold, Cell-Therapy Based)

In soft tissue repair market, fixation devices segment is predicted to capture over 50% revenue share by 2037. The segment growth can be attributed to the growing prevalence of fractures and sports injuries. Fixation devices serve as an alternative for the bone structure and are composed of synthetic materials. As the bones heal after surgery or an injury, they serve to stabilize and support them. A wide range of ailments, such as fractures and sports injuries, may be treated with fixation devices.

Interference screws and suture anchors are a couple of the fixing tools. Suture anchors are frequently employed in arthroscopic surgery and sports medicine as essential instruments for fastening soft tissue to the bone.  Further, the interference screw is a direct tendon-to-bone interference fixing tool. By reaching out and compressing the graft with the screw threads, this common compression fixation tool fixes the graft. Thus, during the forecast period, the growing necessity for fixation devices in soft tissue repair will propel the segment's expansion.

End-User (Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Physician Office)

The hospitals & clinics segment in the soft tissue repair market is predicted to account for a share of 46% during the forecast timeframe. The segment’s growth is led by the growing number of hospitals. The number of hospitals globally as of 2021 was estimated to be approximately 164,000.  Furthermore, there has been a surge in investment in the hospital sector. Therefore, medical technology and healthcare administration techniques have become more innovative as a result of the growing investments in the field. Hence, more people are driving for orthopedic treatment in hospitals.

Furthermore, several significant medical industry companies are looking into inorganic expansion prospects. Additionally, this will likely end up resulting in more beds being added as a result of mergers and acquisitions. Therefore, this is estimated to boost the segment growth hence further influencing the market revenue.  

Our in-depth analysis of the global market includes the following segments:

     Product Type

  • Fixation Devices
  • Tissue Scaffold
  • Cell-Therapy Based

     End-user

  • Hospitals & Clinics
  • Ambulatory Surgical Centers [ASCs]
  • Physician Office
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.


Soft Tissue Repair Industry-Regional Synopsis

North America Market Statistics

Soft tissue repair market in the North America is anticipated to hold the largest with a share of about 35% by the end of 2037. The market growth in the region is also expected on account of the increasing expenditure on healthcare. The amount spent on health care in the United States increased by over 3% in 2022 to approximately USD 3 trillion, or over USD 13,492 per person. Furthermore, this region has the presence of key players focused on the field of soft tissue repair.

Additionally, this region has experienced significant launch of advanced products which is why the market in this region is growing. Additionally, government legislation supporting the healthcare system, the need to lower healthcare costs, and the prevalence of chronic diseases are all important factors.

APAC Market Analysis

The Asia Pacific region will also encounter enormous growth for the soft tissue repair market during the forecast period and will hold the second position owing to the rising disposable income in this region. Hence, the willingness of people to spend more on soft tissue repair treatment is growing in this region.

Furthermore, there has been continuous growth in research in this field which is also projected to dominate the market expansion. Also, this region is experiencing an upward movement in medical tourism due to the upgradation in technology. 

Soft Tissue Repair Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Soft Tissue Repair Landscape

    • 3D Systems
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Biocomposites
    • Medtronic plc
    • Stryker
    • Zimmer Biomet
    • Arthrex, Inc.
    • ConMed Corporation
    • Acumed, LLC
    • Integra LifeSciences
    • ArthroCare Corporation

     


Recent Developments

  • 3D Systems, the premier additive manufacturing solutions partner, and Theradaptive, a biopharmaceutical firm pioneering tailored regenerative treatments, announced a commercial agreement that designates 3D Systems as Theradaptive's exclusive 3D printing partner. The businesses seek to provide a revolutionary strategy to promoting bone and tissue regeneration by coating 3D Systems' 3D-printed medical devices with Theradaptive's unique protein-based material-binding variations. This solution has the potential to improve patients' healing and consequently their results.
  • Arthrex, a global leader in minimally invasive surgical technology, revealed that its ACL TightRope implant has been cleared by the US Food and Drug Administration (FDA) for pediatric use. The TightRope implant is used to treat orthopedic injuries surgically, and it is the first and only fixation device for anterior cruciate ligament (ACL) injuries that has been certified for pediatric usage. The Arthrex all-epiphyseal approach was designed for skeletally immature patients and entails bypassing the juvenile growth plates when repairing or reconstructing the ACL.
  • Report ID: 5530
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

Frequently Asked Questions (FAQ)

Soft Tissue Repair Market in 2025 is estimated at USD 16.13 billion.

The global market size was valued at more than USD 15.34 billion in 2024 and is expected to register a CAGR of more than 6.4%, exceeding USD 34.36 billion revenue by 2037.

North America is set to approach USD 12.03 billion by 2037, attributed to increased healthcare expenditure and presence of key players.

The major players in the market include 3D Systems, Biocomposites, Medtronic plc, Stryker, Zimmer Biomet, Arthrex, Inc., ConMed Corporation, Acumed, LLC, Integra LifeSciences, ArthroCare Corporation.
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.


Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos